§ BIOTECHNOLOGY
USD · Biotechnology

CATX

PERSPECTIVE THERAPEUTICS INC
USDSector · Biotechnology
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
88 increased/new, 28 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
TCG Crossover Management, LLC7.9M0.9%n/a
Commodore Capital LP6.3M1.5%n/a
Avidity Partners Management LP6.0Mn/a+88%
BlackRock, Inc.5.3M0.0%+17%
Opaleye Management Inc.4.9M2.7%n/a
VANGUARD CAPITAL MANAGEMENT LLC4.4Mn/an/a
◇ AC INTELLIGENCE

Top institutional owners for CATX as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER21.3% · 0 holders
OTHER50.8% · 84 holders
TACTICAL / MACRO9.4% · 5 holders
DEALER / BANK8.9% · 21 holders
PASSIVE / INDEX7.1% · 7 holders
QUALITY / COMPOUNDER1.9% · 10 holders
SYSTEMATIC / QUANT0.3% · 3 holders
INCOME / DEFENSIVE0.2% · 6 holders
GROWTH / MOMENTUM0.1% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for CATX in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention CATX yet.